| 1. |
Call GK, Fleming MC, Sealfon S, et al. Reversible cerebral segmental vasoconstriction. Stroke, 1988, 19(9): 1159-1170.
|
| 2. |
Calabrese LH, Dodick DW, Schwedt TJ, et al. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med, 2007, 146(1): 34-44.
|
| 3. |
Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol, 2012, 11(10): 906-917.
|
| 4. |
Yancy H, Lee-Iannotti JK, Schwedt TJ, et al. Reversible cerebral vasoconstriction syndrome. Headache, 2013, 53(3): 570-576.
|
| 5. |
Calic Z, Choong H, Schlaphoff G, et al. Reversible cerebral vasoconstriction syndrome following indomethacin. Cephalalgia, 2014, 34(14): 1181-1186.
|
| 6. |
郭军红, 牛小媛, 吴晓巍, 等. 可逆性脑血管收缩综合征: 附 1 例报道. 中国康复理论与实践, 2009, 15(12): 1120-1123, 封 3.
|
| 7. |
孙杨, 张雪梅. 可逆性脑血管收缩综合征. 脑与神经疾病杂志, 2018, 26(4): 259-261.
|
| 8. |
杨琴. 可逆性脑血管收缩综合征的诊治进展. 中国医药指南, 2021, 19(10): 21-22.
|
| 9. |
简雯, 沈遥遥. 可逆性脑血管收缩综合征 2 例的临床及影像学特点. 实用临床医学, 2021, 22(1): 7-10, 封 3.
|
| 10. |
Hawkes MA, Hlavnicka AA, Wainsztein NA. Reversible cerebral vasoconstriction syndrome responsive to intravenous milrinone. Neurocrit Care, 2020, 32(1): 348-352.
|
| 11. |
Marks GS. A sophisticated technique for measurement of nitric oxide: implications for the mechanism of action of nitroglycerin. J Lab Clin Med, 1992, 120(6): 826-827.
|
| 12. |
Matsuda C, Hayashi S, Kinouchi K. The effect of nitroglycerin 200 microg on uterine relaxation during cesarean delivery. Masui, 2013, 62(4): 390-394.
|
